Mentice’s CEO to BioStock: “We anticipate a further ramp up in our sales”

Mentice reported strong growth in the first quarter of 2025, with revenues reaching SEK 53.3 million – an increase of 19.5 per cent compared to the same period last year. However, profitability was affected by a challenging macroeconomic environment and unfavourable currency effects. BioStock reached out to CEO Frans Venker to learn more about the company’s performance and strategic outlook.

Läs hela artikeln på biostock.se:

https://www.biostock.se/2025/05/mentices-ceo-we-anticipate-a-further-ramp-up-in-our-sales/

Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital. https://www.biostock.se